Results 51 to 60 of about 920 (164)

CINtec PLUS cytology as a cervical cancer screening test at the IPO of Porto

, 2022
Cervical squamous cell carcinoma of the cervix is the fourth most common cancer between women and seventh globally. There are many women undergoing colposcopy without real need, so more effective screening tests are needed to decide who among HPV-positive women should receive additional diagnostic evaluation to avoid unnecessary colposcopies.
Alves, Ana, Lopes, Ana Paula, Granja, Sara, Quintela Vieira, Filipa, Silva, Regina Augusta   +4 more
openaire   +1 more source

DNA‐Methylation for Risk‐Stratification of Women Without a Fully Visible Transformation Zone at Colposcopy: A Cross‐Sectional Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To evaluate the performance of DNA methylation markers for the detection of cervical precancer among screening‐positive older women without a fully visible transformation zone at colposcopy (TZ3). Design Cross‐sectional study. Setting Colposcopy clinics, Central Denmark Region, 2019–2021.
Karen Omann Binderup, Joachim Boers, Line Winther Gustafson, Berit Andersen, Lone Kjeld Petersen, Pinar Bor, Joost Gribnau, Wim G. V. Quint, Henk Van Den Munckhof, Mette Tranberg, Anne Hammer   +10 more
wiley   +1 more source

CERVIS: Cervical Cancer Early Response Visual Identification System [PDF]

, 2019
The goal of CERVIS is to make a substantial, positive impact in the cervical cancer screening space through the development of a minimally invasive, cost effective solution that enables women in low-resource settings to test for cervical cancer on a ...
Hultquist, Claire, Lanoha, Julia, McDonagh, Rosie, McNamara, Hallie   +3 more
core   +1 more source

Role of Protein Biomarkers in the Detection of High-Grade Disease in Cervical Cancer Screening Programs [PDF]

, 2012
Since the Pap test was introduced in the 1940s, there has been an approximately 70% reduction in the incidence of squamous cell cervical cancers in many developed countries by the application of organized and opportunistic screening programs.
Bogers, Johnannes, Brown, Charlotte A., De Prins, Frans, Depuydt, Christophe E., Malinowski, Douglas P., Sahebali, Shaira   +5 more
core   +4 more sources

CURRENT APPROACHES FOR HPV-ASSOCIATED CIN

Мать и дитя в Кузбассе, 2020
The aim of the study was to determine the frequency of expression of р16/Ki-67 in the cervical epithelium of patients with HPV-associated CIN of various degrees according to immunocytochemical studies in comparison with patients without cervical ...
Татьяна Владимировна Клинышкова, Ольга Николаевна Миронова   +1 more
doaj  

Reparative Spheroids in HPV-Associated Chronic Cervicitis [PDF]

, 2013
Background: Spheroid cell structures (SCS) described in cell culture are used to study cell-cell and cell-matrix interactions. However, the role of the SCS in the repair process in vivo remains unexplored. The aim of the study was to examine the cellular
Evgeniya A. Kogan, Gennadiy T. Sukhikh, Nafisa M. Fayzullina, Tatyana A. Demura   +3 more
core  

Cell-Cycle Protein Expression in a Population-Based Study of Ovarian and Endometrial Cancers [PDF]

, 2015
Aberrant expression of cyclin-dependent kinase (CDK) inhibitors is implicated in the carcinogenesis of many cancers, including ovarian and endometrial cancers.
Ashley S. Felix, Hannah P. Yang, Jolanta Lissowska, Kris Ylaya, Louise A. Brinton, Mark E. Sherman, Munira Z. Gunja, Nicolas Wentzensen, Renata L. Cora, Stephen M. Hewitt, Vicky Boudreau   +10 more
core   +2 more sources

Clearance of senescent decidual cells by uterine natural killer cells in cycling human endometrium [PDF]

, 2017
In cycling human endometrium, menstruation is followed by rapid estrogen-dependent growth. Upon ovulation, progesterone and rising cellular cAMP levels activate the transcription factor Forkhead box O1 (FOXO1) in endometrial stromal cells (EnSCs ...
Acosta, Aird, Al-Sabbagh, Barros, Bradford, Childs, Chowdhury, de Keizer, de Ziegler, Demidenko, Diep, Dimri, Drury, Erlebacher, Evans, Funayama, Gellersen, Groll, Hanna, Hapangama, Iannello, Krizhanovsky, Laws, Lucas, Lucas, Marçais, Matjusaitis, Mosteiro, Murakami, Muñoz-Espín, Paria, Park, Pfaffl, Pohnke, Rajagopalan, Ritschka, Ruifrok, Sadaie, Saeed, Sagiv, Sagiv, Salker, Smith, Takano, Team, van Deursen, Venables, Xiong, Yuan, Zhang, Zhu, Zhu   +51 more
core   +2 more sources

Prognostic impact of p16 and high‐risk HPV DNA in ~1300 patients with vulvar cancer

International Journal of Cancer, Volume 157, Issue 7, Page 1354-1362, 1 October 2025.
What's New? Vulvar cancer (VSCC) is rare, and little is known about early prognostic factors that could contribute to an individualized treatment plan. About 30%–40% of VSCCs are associated with human papillomavirus (HPV). Here, the authors investigated the prognostic influence of p16 status in VSCC in a large cohort of 1300 patients.
Susanne K. Kjær, Kirsten Frederiksen, Christina L. Rasmussen, Louise T. Thomsen, Else M. Madsen, Maria B. Franzmann, Alexander K. Kjær, Lise G. Larsen, Nadia V. Salinas, Doris Schledermann, Birgitte H. Winberg, Pernille T. Jensen, Dorthe Ørnskov, Marianne Waldstrøm, Louise Baandrup   +14 more
wiley   +1 more source

Actualités sur le dépistage et la prévention des infections à VPH dans le cadre des cancers du col utérin [Current developments in uterine cervical carcinoma prevention and screening] [PDF]

, 2015
The causality between the HPV infection and the carcinoma of the uterine cervix is demonstrated. The benefits of the prophylactic HPV vaccine are emerging in the general population. This vaccine has no evident general side effect.
Jacot-Guillarmod, M., Mathevet, P.
core